Back to Authors

Locke, Frederick L.

https://orcid.org/0000-0001-9063-6691

A5021394406 | I3019308854

Mayo Clinic

Moffitt Cancer Center

Citations 112

PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI‐CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL)

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 262-263

10.1002/hon.2438_132

AXICABTAGENE CILOLEUCEL (AXI‐CEL; KTE‐C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA‐1

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 28-28

10.1002/hon.2437_7